Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
SuRo Capital Corp. First Quarter 2025 Preliminary Investment Portfolio Update
09:05am, Monday, 07'th Apr 2025
SuRo Capital Portfolio Investment CoreWeave Completes Largest Tech IPO Since 2021 SuRo Capital Portfolio Investment OpenAI Closes Largest Venture Raise with $300 Billion Valuation Net Asset Value Anti
5 Top-Ranked Stocks of Nasdaq ETF Beating the Bear Market
09:00am, Monday, 07'th Apr 2025
The tech-focused Nasdaq officially entered bear market territory on Friday, falling over 20% from its December peak.
Blue Hat Regains Compliance with Nasdaq Minimum Bid Price Requirement
08:30am, Monday, 07'th Apr 2025
XIAMEN, China, April 07, 2025 (GLOBE NEWSWIRE) -- Blue Hat Interactive Entertainment Technology (“Blue Hat” or the “Company”) (NASDAQ: BHAT), a Cayman Islands company, today announced that on
Devon Energy Rallied Nearly 15% in Q1 While the Nasdaq Had Its Worst Quarter Since the Bear Market
05:38am, Monday, 07'th Apr 2025
Devon Energy (DVN -11.67%) got off to a great start in 2025. The oil company's stock price surged 14.3% in the first quarter, according to data from S&P Global Market Intelligence.
Tariff Turmoil: 2 Spectacular Stocks to Confidently Buy With $1,500 During the Nasdaq Correction
05:03am, Monday, 07'th Apr 2025
On April 2, President Trump announced sweeping tariffs on America's trading partners, which will increase the cost of physical goods coming into the country. The president's goal is to encourage more
Could Investing $25,000 in the Nasdaq-100 Make You a Millionaire?
10:04am, Saturday, 05'th Apr 2025
Investing in the best growth stocks in the world can be a great way to build up your wealth over the years. One top index that contains many fast-growing businesses is the Nasdaq-100, which contains t
BioHarvest CEO talks Nasdaq uplisting, profit targets - ICYMI
09:49am, Saturday, 05'th Apr 2025
BioHarvest Sciences Inc. (NASDAQ:BHST) earlier this week reported its financial results for 2024, showing a 99.00% year-over-year increase in revenue to 25.20 million US dollars. The company said four
This ETF Might Look Like a Clever New Way to Invest in the Nasdaq-100, but Don't Outsmart Yourself
04:15am, Saturday, 05'th Apr 2025
When most investors think of a market index, the S&P 500 (^GSPC -5.97%) probably comes to mind. That makes sense since it is the go-to measure of broad stock performance.
Down 15% in 1 Month, Is This Dividend Stock a No-Brainer Buy on the Nasdaq Correction?
04:05am, Saturday, 05'th Apr 2025
The Nasdaq Composite (^IXIC -5.82%) is down 14.1% from its 52-week high, putting it in correction territory.
Nasdaq Bear Market: 2 Brilliant Stocks Down 53% and 67% to Buy Before They Double, According to Wall Street
03:03am, Saturday, 05'th Apr 2025
The Nasdaq Composite (^IXIC -5.82%) recently entered a bear market, which means the technology-focused index has tumbled more than 20% from its record high. But most Wall Street analysts see the decli
B. Riley Financial Announces Notification of Delinquency with Nasdaq
04:30pm, Friday, 04'th Apr 2025
LOS ANGELES , April 4, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (Nasdaq: RILY) (the "Company") today announced it received an expected delinquency notification letter from Nasdaq on April 3, 20
eHealth, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 04'th Apr 2025
AUSTIN, Texas , April 4, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) ( ehealth.com ), a leading private online health insurance marketplace (the "Company"), today announced that on Ap
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 04'th Apr 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies f
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 04'th Apr 2025
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 04'th Apr 2025
SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / April 4, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective April 3, 2025, the Company granted 3,600 res
